Viridian Therapeutics, Inc. (VRDN) Tops Q1 EPS by 99c

Viridian Therapeutics, Inc. (NASDAQ: VRDN) reported Q1 EPS of ($0.09), $0.99 better than the analyst estimate of ($1.08). Revenue for the quarter came in at $140 thousand versus the consensus estimate of $33.31 thousand.

For earnings history and earnings-related data on Viridian Therapeutics, Inc. (VRDN) click here.

You May Also Be Interested In

• Venu Holding (VENU) PT Lowered to $8.70 at Freedom Broker
• Deere & Co. (DE) call put ratio 1.1 calls to 1 put into quarter results
• Viking (VIK) call put ratio 1.7 calls to 1 put into quarter results